Using survival data derived from UCSC Xena based on the TCGA datasets, we evaluated the impact of CD276 expression levels on overall survival (OS) in patients with lung adenocarcinoma and lung squamous cell carcinoma by Kaplan-Meier survival analysis (Figure 1B). This evidence concerns the gene CD276 and lung adenocarcinoma.